"Design And Fabrication Of Injectable Alginate Hydrogel Microstrands Fo" by Sujith Chander Reddy Kollampally

Date of Award

5-1-2024

Language

English

Document Type

Dissertation

Degree Name

Doctor of Philosophy (PhD)

College/School/Department

Department of Nanoscale Science and Engineering

Dissertation/Thesis Chair

Yubing Xie

Committee Members

Susan T Sharfstein, Melinda Larsen, Andre J Melendez, Xulang Zhang

Keywords

Alginate, Mechanical testing, Mesenchymal stem cells, Microstrands, Salivary glands, Tissue Regeneration

Subject Categories

Nanoscience and Nanotechnology

Abstract

Fibrosis is a pathological wound healing process, driven by excessive accumulation of extracellular matrix (ECM) following tissue remodeling. Fibrosis occurs in diseased or damaged salivary glands caused by several conditions, such as Sjogren’s syndrome or radiation for head and neck cancers. Having better insight into the cellular and molecular progression of fibrosis will allow us to model new therapeutic approaches as fibrosis prevents salivary gland tissue regeneration and function. Pharmacological, tissue engineering and cell-based regeneration strategies have been widely explored to restore lost salivary gland function. Among cell-based therapies, exploitation of mesenchymal stromal/stem cells (MSC) for salivary gland regeneration has been actively pursued due to their anti-fibrotic and anti-inflammatory properties. However, the therapeutic potential of MSC-based therapies relies on successful migration and engraftment of cells to the diseased or injured site of the tissue or organ. Despite their immunomodulatory properties, MSCs need a delivery vehicle, which can support their growth and allow them to maintain their functional characteristics (phenotype) during transplantation. FDA-approved, biocompatible alginate hydrogels in the form of microstrands have great potential to deliver MSCs at the site of injured tissue due to their ECM mimicking properties, ease of chemical modulations, ease of handling for implantation. Microstrands of diameters ≤200 µm do not limit diffusion of oxygen, nutrients, cytokines, or growth factors unlike bulk hydrogels. In this work, we address the unmet limitations of current fabrication methodologies of cell-laden microstrands using vacuum-driven devices. Two types of devices were designed, developed and optimized to fabricate alginate hydrogel microstrands of desired diameter with high repeatability and reproducibility. We also demonstrated that cell-laden alginate microstrands of different cell types, fabricated using these devices, were able to maintain high cell viability, high-density growth, and homeostatic marker expression. We also determined how factors, such as supplemental calcium ions and high cell-seeding density, affect the mechanical properties of alginate hydrogel microstrands with time. Further, we explored the feasibility of fabricating small-volume alginate hydrogel microstrands (as low as 25 µL) and using these cell-laden microstrands as cell delivery vehicles for in vivo MSC implantation experiments. Overall, in this work, we have developed devices to fabricate injectable cell-laden alginate hydrogel microstrands for cell delivery and in vivo tissue regeneration, including MSC delivery to fibrotic salivary glands.

Share

COinS